RecruitingRecruiting
Wearable for Assessing Tremor and Continuous Health in Parkinson's Disease and Essential Tremor
NCT07787299 · Heriot-Watt University
In plain English
Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.
Official title
Wearable for Assessing Tremor and Continuous Health in Parkinson's and Essential Tremor Diseases
About this study
The study will recruit up to 60 adults through NHS Lothian: 40 with Parkinson's disease and 20 with essential tremor. During the clinic visit, participants will complete clinical assessments and movement tasks while wearing the PD-WATCH research sensor and comparator wearable sensors. Participants allocated to home monitoring will wear the sensors during usual daily activities and complete brief medication, symptom, and activity logs. The study will describe wearable-derived movement features, explore their relationships with clinical assessments and medication timing, and assess the feasibility and acceptability of wearable monitoring. The study is exploratory and is not designed to evaluate diagnostic accuracy, treatment effects, or device performance.
Eligibility criteria
Inclusion Criteria:
1. Aged 18 years or older.
2. Clinical diagnosis of idiopathic Parkinson's disease (Hoehn and Yahr stage I-III) or essential tremor.
3. Motor or tremor symptoms confirmed on clinical assessment.
4. Able to walk at least 4 metres independently, with or without a walking aid.
5. Able to provide written informed consent and comply with study procedures.
6. Willing and able to wear the study sensors in clinic and, where applicable, at home.
7. Able to understand study information and complete study materials in English.
Exclusion Criteria:
1. A recent major cardiovascular or cerebrovascular event, or another unstable condition that would make participation unsafe.
2. An uncontrolled psychiatric disorder, ongoing substance misuse, active systemic cancer treatment, or another serious illness likely to interfere with participation.
3. Pregnancy at enrolment.
4. Active skin disease or known allergy to adhesive plaster at anticipated sensor sites.
5. Dementia with Lewy Bodies, atypical, vascular, or drug-induced parkinsonism.
6. Previous invasive neuromodulation or neurosurgery for a movement disorder, including deep brain stimulation.
7. Current or recent participation in another interventional study that could affect safety or study outcomes.
8. In the investigator's opinion, unable to complete the study procedures safely.
Study design
Enrollment target: 60 participants
Age groups: adult, older_adult
Timeline
Starts: 2026-11-01
Estimated completion: 2027-12-31
Last updated: 2026-10-09
Interventions
Device: Device exposure: Wearable inertial sensor monitoring
Primary outcomes
- • Wearable sensor data completeness for tremor and upper-limb movement analysis (Day 1 through completion of home monitoring, up to 22 days.)
- • Completeness of paired wearable and clinical assessment data (Day 1.)
- • Participant-rated device comfort and usability score (Day 1 and at completion of home monitoring, up to 22 days.)
Sponsor
Heriot-Watt University · other
With: NHS Lothian
Contacts & investigators
ContactGordon Duncan · contact · gordon.duncan2@nhs.scot · +44 131 537 3804
ContactAnne Bernassau · contact · a.bernassau@hw.ac.uk · +44 131 451 3358
InvestigatorAnne Bernassau · study_chair, Heriot-Watt University
InvestigatorGordon Duncan · principal_investigator, NHS Lothian
All locations (1)
Clinical Research Facility, Western General Hospital, NHS LothianRecruiting
Edinburgh, Edinburgh, United Kingdom